Macromoltek

https://www.ycombinator.com/companies/macromoltek

Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

About
  • Year Founded: 2010
  • Number of Founders: 2
  • HQ: Austin, Texas, United States
  • Domain: macromoltek.com
  • Industries: Pharmaceutical, Biotechnology, Biopharma
  • Tags: ai-powered-drug-discovery, deep-learning, therapeutics
  • Total Funding: 1492194
  • Number of Funding Rounds: 4.0
  • Last Funding Round Type: Seed
  • Last Funding Date: 2018-03-22
  • Team Size: 14
  • Founder Names: Monica Berrondo, Susana Kaufmann
Related Companies
Contacts